About Contact Us Careers
Sign In

Microchips in Medicine Market - Top Companies and Manufacturers

  • Report ID: 3734
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Companies Dominating the Microchips in Medicine Landscape

    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Applied Microarrays Inc.
    • RELX Group
    • QIAGEN
    • Agilent Technologies, Inc.
    • INTROMEDIC
    • Otsuka America Pharmaceutical, Inc.
    • Medtronic Plc
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
Browse Key Market Insights with Data Illustration:

In the News

  • Thermo Fisher Scientific, Inc., announced it has acquired Belgium-based PharmaFluidics, a manufacturer of micro-chip-based chromatography columns. The acquisition will enable Thermo Fisher to expand its portfolio of chromatography and mass spectrometry solutions. It will also provide customers with access to advanced technology for analyzing complex samples.
  •  Medtronic plc has announced Cosmo Pharmaceuticals and NVIDIA are planning to integrate their AI technology into its intelligent endoscopy module, GI Genius. By using AI-assisted technology, physicians will be able to detect potentially cancerous polyps more quickly and accurately, leading to better patient outcomes.

Author Credits:  Radhika Pawar


  • Report ID: 3734
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of microchips in medicine is evaluated at USD 1.13 Billion.

The microchips in medicine market size was over USD 1.07 Billion in 2023 and is likely to exceed USD 2.45 Billion by the end of 2036, witnessing over 6.6% CAGR during the forecast period i.e., between 2024-2036. Increasing popularity of microchip implants in healthcare to improve patient outcomes and the increasing trend of digitalization in healthcare are the major factors driving the growth of the market.

North America industry is predicted to account for the largest share of 35% by 2036, impelled by growing spending in healthcare in the region.

Thermo Fisher Scientific Inc., Applied Microarrays Inc., RELX Group, QIAGEN, Agilent Technologies, Inc., INTROMEDIC, Otsuka America Pharmaceutical, Inc., Medtronic Plc, Illumina, Inc., Bio-Rad Laboratories, Inc.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample